Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
QLI Stock Forecast 2025-2026
$7.18
Current Price
$38.68M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to QLI Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
QLI Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
+96.7%
1 Year Change
0.0%
Year-to-Date Change
-19.9%
From 52W High of $8.96
+304.4%
From 52W Low of $1.78
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Qilian International (QLI) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on QLI and similar high-potential opportunities.
Latest QLI Stock Price Targets & Analyst Predictions
QLI has shown a year-to-date change of 0.0% and a 1-year change of 96.7%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for QLI. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
QLI Analyst Ratings
0
Buy
0
Hold
0
Sell
QLI Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $7.18
Latest QLI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for QLI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Qilian International Holding Group Ltd. (QLI) Competitors
The following stocks are similar to Qilian International based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Qilian International Holding Group Ltd. (QLI) Financial Data
Qilian International Holding Group Ltd. has a market capitalization of $38.68M with a P/E ratio of 0.0x. The company generates $46.47M in trailing twelve-month revenue with a -16.7% profit margin.
Revenue growth is -47.2% quarter-over-quarter, while maintaining an operating margin of -16.3% and return on equity of -16.4%.
Valuation Metrics
Market Cap
$38.68M
Enterprise Value
$18.40M
P/E Ratio
0.0x
PEG Ratio
0.0x
Price/Sales
0.8x
Growth & Margins
Revenue Growth (YoY)
-47.2%
Gross Margin
N/A
Operating Margin
-16.3%
Net Margin
-16.7%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+43.7%
Current Ratio
5.2x
Debt/Equity
1.3x
ROE
-16.4%
ROA
-2.8%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Qilian International Holding Group Ltd. (QLI) Business Model
About Qilian International Holding Group Ltd.
What They Do
Manufactures and distributes pharmaceutical ingredients and products.
Business Model
The company generates revenue by manufacturing and distributing active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivatives (TCMD). It supplies various products, including licorice-based medicines, veterinary pharmaceuticals, and organic fertilizers, to pharmaceutical companies and other industries, thereby establishing multiple revenue streams from both healthcare and agricultural sectors.
Additional Information
Incorporated in 2019, the company is based in Jiuquan, China, and focuses on leveraging traditional medicine alongside modern agricultural solutions. Its diverse product portfolio includes both medicinal and organic solutions, catering to a broad market that spans pharmaceuticals, agriculture, and food industries.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
298
CEO
Country
China
IPO Year
2014
Website
www.qlsyy.netQilian International Holding Group Ltd. (QLI) Latest News & Analysis
Latest News
Quick Summary
Qilian International Holding Group Ltd. will change its name to BGM Group Ltd. effective October 30, 2024. The stock trades on NASDAQ under the symbol BGM.
Why It Matters
The name change to BGM Group Ltd. may signal a rebranding effort, potentially impacting investor perception, company strategy, and market positioning.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Qilian International Holding Group Ltd. (NASDAQ: QLI) will begin trading its Class A ordinary shares under the new ticker symbol "BGM" on the Nasdaq Capital Market effective August 11, 2024.
Why It Matters
Qilian's shift to the Nasdaq Capital Market and new ticker symbol "BGM" may affect liquidity and investor interest, potentially impacting share price and market perception.
Source: PRNewsWire
Market Sentiment:
Neutral
Qilian International Holding Group Ltd Regained Compliance with Nasdaq's Minimum Bid Price Rule
10 months ago
Quick Summary
Qilian International Holding Group (NASDAQ: QLI) has regained compliance with NASDAQ Listing Rule 5550(a)(2) after its shares closed above $1.00 for 10 consecutive business days.
Why It Matters
Qilian International's compliance with NASDAQ listing rules boosts investor confidence, indicating stability and potential for growth, which can positively impact share prices.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Qilian International Holding Group (NASDAQ:QLI) will execute a 1-for-5 reverse stock split effective June 21, 2024, approved by its board on May 29, 2023.
Why It Matters
The reverse stock split may signal efforts to boost share price and attract institutional investors, impacting liquidity and investor perception of Qilian's stability and growth potential.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Qilian International Holdings Group Limited (NASDAQ: QLI) reports challenges due to decreased demand and prices for oxytetracycline, alongside rising production costs, impacting profitability.
Why It Matters
Qilian's declining demand and increased costs for oxytetracycline signal potential revenue drops, impacting profitability and stock performance, which may concern investors about future growth.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Qilian International (NASDAQ: QLI) received a 180-day extension from Nasdaq until July 8, 2024, to meet the minimum bid price requirement of $1.00 per share for compliance.
Why It Matters
Qilian International has until July 8, 2024, to meet Nasdaq's minimum bid price requirement, affecting its listing status and investor confidence in its stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About QLI Stock
What is Qilian International Holding Group Ltd.'s (QLI) stock forecast for 2025?
Analyst forecasts for Qilian International Holding Group Ltd. (QLI) are not currently available. The stock is trading at $7.18.
Is QLI stock a good investment in 2025?
Analyst ratings for QLI are not currently available. The stock is currently trading at $7.18. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for QLI stock?
Price predictions from Wall Street analysts for QLI are not currently available. The stock is trading at $7.18.
What is Qilian International Holding Group Ltd.'s business model?
The company generates revenue by manufacturing and distributing active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivatives (TCMD). It supplies various products, including licorice-based medicines, veterinary pharmaceuticals, and organic fertilizers, to pharmaceutical companies and other industries, thereby establishing multiple revenue streams from both healthcare and agricultural sectors.
What is the highest forecasted price for QLI Qilian International Holding Group Ltd.?
Price targets from Wall Street analysts for QLI are not currently available. The stock is trading at $7.18.
What is the lowest forecasted price for QLI Qilian International Holding Group Ltd.?
Price targets from Wall Street analysts for QLI are not currently available. The stock is trading at $7.18.
What is the overall QLI consensus from analysts for Qilian International Holding Group Ltd.?
Analyst ratings for QLI are not currently available. The stock is trading at $7.18.
How accurate are QLI stock price projections?
Stock price projections, including those for Qilian International Holding Group Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 11, 2025 4:58 PM UTC